Investor insights
Sectors invested in
Funding rounds participated in
$30M sweet spot round size
Most of their 13 investments are in rounds between $20M and $100M
Investor type
Basic info
Industry
Sectors
Date founded
2015
Investments made
CG Oncology raised $120M on November 15, 2022
Investors: RA Capital Management, L.P., Acorn Bioventures, Sirona Capital, Longitude Capital, Decheng Capital and ORI Capital Limited
AffyImmune Therapeutics raised $20M on October 7, 2021
Investors: ORI Capital Limited
CG Oncology raised $47M on December 10, 2020
Investors: Perseverance Capital Management, Camford Capital, Kissei Pharmaceutical Co Ltd and ORI Capital Limited
Pillar Biosciences Incorporated raised $30M on May 12, 2020
Investors: HB Ventures/ 木槿资本 and ORI Capital Limited
CG Oncology raised $22M on March 18, 2019
Investors: Perseverance Capital Management and ORI Capital Limited
Enable Injections, Inc. raised $50M on October 25, 2018
Investors: Ohio Innovation Fund, CincyTech USA, Partisan Management Group Inc and ORI Capital Limited
Orchard Therapeutics raised $110M on December 20, 2017
Investors: UCL Technology Fund, F-Prime Capital Partners, Temasek, RTW Investments, LP, Agent Capital, Cowen Inc., Baillie Gifford and ORI Capital Limited
Semma Therapeutics raised $114M on November 29, 2017
Investors: Sinopharm Capital 国药资本, F-Prime Capital Partners, JDRF T1D Fund, Wu Capital （双湖资本）, MPM Capital, Cowen Inc. and ORI Capital Limited
Arterys raised $30M on November 15, 2017
Investors: GE Ventures, Temasek, Varian Medical Systems, DNA Capital and ORI Capital Limited
TriSalus Life Sciences raised $13M on March 3, 2017
Investors: Partisan Management Group Inc and ORI Capital Limited